The Chinese pharmaceutical manufacturer CanSino Biologics announced it would hold talks with several EU countries about a possible order for its Covid-19 vaccine. Three European Union member states had approached the Tianjin-based vaccine developer to discuss a possible purchase, Pierre Morgon, CanSino’s Senior Vice President in charge of international business, confirmed to China.Table. Morgon would not disclose which EU countries were involved, citing ongoing talks.
Continue reading now
Get 30 days of free access to the Decision Brief to read these and more quality news every day.
Are you already a guest at the China.Table? Log in now